Pharmaceutical Preparations · DE · CIK 1410098
CorMedix develops and commercializes therapeutic products for life-threatening diseases, including DefenCath for hemodialysis and infectious disease treatments
Comparable business profile · signals at a glance
In the 90 days to Jan 21, 2026: 1 insider bought $276K · 4 sold $2.6M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 21, 2026 | Dillione JanetDirector | Sell | 10,000 | $6.88 | $69K |
| Dec 30, 2025 | Dunton Alan WDirector | Sell | 20,000 | $13.00 | $260K |
| Dec 18, 2025 | Todisco JosephChief Executive Officer | Sell | 30,000 | $12.00 | $360K |
| Dec 9, 2025 | Lefkowitz Steven WDirector | Sell | 40,000 | $11.88 | $475K |
| Dec 9, 2025 | Dillione JanetDirector | Sell | 34,000 | $12.00 | $408K |
| Dec 2, 2025 | Dillione JanetDirector | Sell | 46,657 | $10.00 | $467K |
| Nov 24, 2025 | Dillione JanetDirector | Sell | 26,343 | $9.93 | $262K |
| Nov 14, 2025 | Dillione JanetDirector | Sell | 30,000 | $11.42 | $343K |
| Oct 23, 2025 | Kaplan MyronDirector | Buy | 25,000 | $11.02 | $276K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.